Evolent Health (EVH) Non-Current Debt (2016 - 2026)

Evolent Health has reported Non-Current Debt for 11 years, with the latest figure at $966.5 million in Q2 2026.

• On a quarterly basis, Non-Current Debt rose 49.04% year-over-year to $966.5 million in Q2 2026; TTM through Jun 2026 was $966.5 million, a 49.04% increase from a year earlier, with the FY2025 full-year figure at $970.5 million, up 97.86% from the prior year.
• Non-Current Debt was $966.5 million for Q2 2026 at Evolent Health, down from $973.5 million in the prior quarter.
• The five-year high for Non-Current Debt was $1.1 billion in Q3 2025, with the low at $282.6 million in Q1 2022.
• Average Non-Current Debt over 5 years is $633.4 million, with a median of $599.8 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Non-Current Debt surged 123.74% in 2023, then retreated 17.84% in 2024.
• Over 5 years, Non-Current Debt stood at $413.0 million in 2022, then jumped by 44.57% to $597.0 million in 2023, then declined by 17.84% to $490.5 million in 2024, then surged by 97.86% to $970.5 million in 2025, then declined by 0.42% to $966.5 million in 2026.
• The last three Non-Current Debt figures came in at $966.5 million (Q2 2026), $973.5 million (Q1 2026), and $970.5 million (Q4 2025), per Business Quant data.